Big Pharma Split Corp Class A (PRM) — Free Cash Flow Generation Index
Big Pharma Split Corp Class A (PRM) has a Free Cash Flow Generation Index of 1.00x as of September 2023. Free cash flow of CA$644.28K represents 1% of operating cash flow (CA$644.28K). Read Big Pharma Split Corp Class A balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Big Pharma Split Corp Class A Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for Big Pharma Split Corp Class A across 5 annual periods. Explore capital reinvestment ratio of Big Pharma Split Corp Class A to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Big Pharma Split Corp Class A (2018–2023)
Year-by-year Free Cash Flow Generation Index for Big Pharma Split Corp Class A. For the full company profile including market capitalisation, see Big Pharma Split Corp Class A (PRM) market capitalisation.
| Year | FCG Index | Free Cash Flow (CAD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | CA$11.86 Million | CA$11.86 Million | CA$3.00 | ▼ 0.0% |
| 2022 | 1.00x | CA$1.13 Million | CA$1.13 Million | CA$0.00 | ▲ +0.0% |
| 2020 | 1.00x | CA$4.35 Million | CA$4.35 Million | CA$3.00 | ▲ +0.0% |
| 2019 | 1.00x | CA$8.68 Million | CA$8.68 Million | CA$0.00 | ▲ +0.0% |
| 2018 | 1.00x | CA$1.27 Million | CA$1.27 Million | CA$0.00 | — |